Sclerotherapy is commonly indicated for telangiectasias and reticular veins

https://www.google.com/maps/d/u/0/edit?mid=1QjJogKY0aIQil7OM04pyLJXDRDd1tvw&ll=42.628989637652%2C-82.86028&z=11

Sclerotherapy is commonly indicated for telangiectasias and reticular veins, delivering targeted therapy that avoids surgical incisions and limits scarring compared to more invasive vein procedures.